Barbara Radecka

1.0k total citations
59 papers, 639 citations indexed

About

Barbara Radecka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Barbara Radecka has authored 59 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Barbara Radecka's work include HER2/EGFR in Cancer Research (19 papers), Brain Metastases and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Barbara Radecka is often cited by papers focused on HER2/EGFR in Cancer Research (19 papers), Brain Metastases and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Barbara Radecka collaborates with scholars based in Poland, United States and Hungary. Barbara Radecka's co-authors include Maria Litwiniuk, Renata Duchnowska, Wojciech Biernat, Jacek Jassem, Bogumiła Czartoryska-Arłukowicz, Tomasz Trojanowski, Anna Kowalczyk, Tomasz Mandat, Bożena Jarosz and Wojciech Olszewski and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Barbara Radecka

50 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Radecka Poland 12 448 297 134 115 77 59 639
Sarah Sammons United States 16 466 1.0× 399 1.3× 168 1.3× 119 1.0× 97 1.3× 92 706
Matteo Clavarezza Italy 13 405 0.9× 135 0.5× 158 1.2× 111 1.0× 90 1.2× 46 629
Melissa Brammer United States 12 585 1.3× 351 1.2× 148 1.1× 81 0.7× 78 1.0× 36 747
Isabelle Desmoulins France 15 361 0.8× 205 0.7× 271 2.0× 84 0.7× 52 0.7× 75 624
Petr Krivorotko Russia 8 213 0.5× 132 0.4× 94 0.7× 131 1.1× 40 0.5× 91 415
Vincenzo Di Lauro Italy 9 229 0.5× 224 0.8× 151 1.1× 167 1.5× 42 0.5× 28 514
Pernelle Lavaud France 12 377 0.8× 290 1.0× 82 0.6× 94 0.8× 21 0.3× 71 551
HS Rugo United States 13 459 1.0× 199 0.7× 189 1.4× 105 0.9× 50 0.6× 49 561
Julio A. Peguero United States 12 368 0.8× 241 0.8× 78 0.6× 133 1.2× 28 0.4× 49 517

Countries citing papers authored by Barbara Radecka

Since Specialization
Citations

This map shows the geographic impact of Barbara Radecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Radecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Radecka more than expected).

Fields of papers citing papers by Barbara Radecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Radecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Radecka. The network helps show where Barbara Radecka may publish in the future.

Co-authorship network of co-authors of Barbara Radecka

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Radecka. A scholar is included among the top collaborators of Barbara Radecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Radecka. Barbara Radecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bieńkowski, Michał, Katarzyna Kuśnierz, Joanna Pilch-Kowalczyk, et al.. (2024). Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma – a prospective single-arm study. Współczesna Onkologia. 28(1). 15–30. 1 indexed citations
3.
Radecka, Barbara, et al.. (2023). Immunotherapy for colorectal cancer. Oncology in Clinical Practice. 19(3). 133–139.
4.
Radecka, Barbara, et al.. (2023). Immunotherapy for gastroesophageal cancer. Oncology in Clinical Practice. 19(3). 140–150. 1 indexed citations
5.
Tajstra, Mateusz, Tomasz A. Rutkowski, Krzysztof Składowski, et al.. (2023). Sacubitril/Valsartan for Cardioprotection in Breast Cancer (MAINSTREAM): Design and Rationale of the Randomized Trial. ESC Heart Failure. 10(5). 3174–3183. 11 indexed citations
6.
Radecka, Barbara, et al.. (2023). Survival of pancreatic cancer patients treated with nab-paclitaxel (nab-P) in clinical practice: analysis of National Health Fund data. Oncology in Clinical Practice. 19(6). 391–397. 1 indexed citations
7.
8.
Radecka, Barbara, et al.. (2021). P-152 Sarcopenia in advanced colorectal cancer patients treated with trifluridine/tipiracil. Annals of Oncology. 32. S151–S151.
9.
10.
Kunc, Michał, Marta Popęda, Anna Szałkowska, et al.. (2020). microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study. Diagnostics. 10(9). 617–617. 8 indexed citations
11.
Pęksa, Rafał, et al.. (2020). Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer. Scientific Reports. 10(1). 1871–1871. 6 indexed citations
12.
Duchnowska, Renata, Rafał Pęksa, Barbara Radecka, et al.. (2016). Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis. Breast Cancer Research. 18(1). 43–43. 83 indexed citations
13.
Radecka, Barbara & Maria Litwiniuk. (2016). Breast cancer in young women. Ginekologia Polska. 87(9). 659–663. 97 indexed citations
14.
Duchnowska, Renata, Jacek Jassem, Chirayu Goswami, et al.. (2015). Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients. Journal of Neuro-Oncology. 122(1). 205–216. 29 indexed citations
15.
Duchnowska, Renata, A. Badzio, Hanna Majewska, et al.. (2015). Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients. Pathology & Oncology Research. 21(4). 1229–1236. 7 indexed citations
16.
Senkus, Elżbieta, Jolanta Szade, Anna J. Żaczek, et al.. (2013). Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype. The Breast. 22(4). 425–430. 1 indexed citations
17.
Duchnowska, Renata, A. Badzio, Hanna Majewska, et al.. (2013). Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: The role of Rad51. The Breast. 22(6). 1178–1183. 14 indexed citations
18.
Duchnowska, Renata, Rafał Dziadziuszko, Tomasz Trojanowski, et al.. (2012). Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Research. 14(4). R119–R119. 77 indexed citations
19.
Duchnowska, Renata, Jacek Jassem, Chirayu Goswami, et al.. (2012). 13-gene signature to predict rapid development of brain metastases in patients with HER2-positive advanced breast cancer.. Journal of Clinical Oncology. 30(15_suppl). 505–505. 6 indexed citations
20.
Duchnowska, Renata, Rafał Dziadziuszko, Bogumiła Czartoryska-Arłukowicz, et al.. (2009). Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. Breast Cancer Research and Treatment. 117(2). 297–303. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Sammons Breakdown of academic impact, for papers by Matteo Clavarezza Breakdown of academic impact, for papers by Melissa Brammer Breakdown of academic impact, for papers by Isabelle Desmoulins Breakdown of academic impact, for papers by Petr Krivorotko Breakdown of academic impact, for papers by Vincenzo Di Lauro Breakdown of academic impact, for papers by Pernelle Lavaud Breakdown of academic impact, for papers by HS Rugo Breakdown of academic impact, for papers by Julio A. Peguero
Rankless by CCL
2026